Ahmet Sevindik
Latest From Ahmet Sevindik
Turkish Medtechs Up In Arms Over Partial Write-Off Of $2Bn+ Hospital Debt
Unpaid hospital debts have been hitting the Turkish medical sector for some time, but a government plan to repay less than the full amount owed has angered industry.
Turkey’s $2.6Bn Hospital Medtech Debts Create Problems On Top Of COVID-19
Turkey’s efforts to control rising rates of COVID-19 are compromising the ability of hospitals to pay their debts to medtech and pharmaceutical companies. The government has devised a payments plan, but there is catch.
COVID-19 Pushes Ongoing Concerns of Turkish Medtech Industry Down The Agenda
The Turkish medtech industry’s ongoing hospital payments problems appeared likely to come back onto the government’s agenda, with the national economy recovering somewhat in late 2019. But COVID-19 dashed those hopes.
Turkey: International Medtechs Demand Stable Pricing And On-Time Payments
Growth prospects for Turkey’s medical technology market are significant, but local companies have complained about public policies that are harmful to business and about the ongoing crisis in the hospital system. Now, international medtechs are starting to react, with some downscaling local operations and portfolios. Association of Research Based Medical Technologies Manufacturers president Umut Gokalp laid out the problems being faced by industry, and what action he thinks the government should take.
Turkey’s Domestic Vaccine Production Drive Prompts New Partnerships
The Turkish government’s drive to establish domestic manufacturing for vaccines is showing tentative signs of getting off the ground. New partnerships are forming between Turkish and international partners. However, lack of local know-how is hampering progress.
Turkey Finally Ups Reimbursement Prices, But Hospital Debts Still Hang Over Medtechs
Late payments of medtech bills by hospitals combined with persistently low reimbursement prices have pushed Turkish device manufacturers to the brink. But after a recent intervention from the industry, the government has finally done something to address industry’s calls for systematic and comprehensive improvement of medtech reimbursement prices.